Sign In
Buy MYOV
$26.98
+0 (+0%)
At Close: Jun 08, 2023
Quantitative Systematic Strategies LLC Acquires Shares of 13,813 Myovant Sciences Ltd (NYSE:MYOV)
10:30am, Sunday, 08'th Mar 2020
Quantitative Systematic Strategies LLC acquired a new stake in Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 13,813 shares of the company’s s
California Public Employees Retirement System Invests $1.06 Million in Myovant Sciences Ltd (NYSE:MYOV)
10:38am, Thursday, 27'th Feb 2020
California Public Employees Retirement System bought a new stake in Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, according to the company in its most recent 13F filing with the Securities a
Myovant Sciences to Present at Upcoming March Investor Conferences
01:30pm, Tuesday, 25'th Feb 2020
BASEL, Switzerland, Feb. 25, 2020 -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer,.
Is the Options Market Predicting a Spike in Myovant (MYOV) Stock?
01:31pm, Friday, 21'st Feb 2020
Investors need to pay close attention to Myovant (MYOV) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Myovant (MYOV) Stock?
01:31pm, Friday, 21'st Feb 2020
Investors need to pay close attention to Myovant (MYOV) stock based on the movements in the options market lately.
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results
09:10pm, Thursday, 20'th Feb 2020
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of
Myovant Sciences (NYSE:MYOV) Announces Earnings Results, Misses Estimates By $0.16 EPS
12:42pm, Wednesday, 12'th Feb 2020
Myovant Sciences (NYSE:MYOV) posted its quarterly earnings results on Monday. The company reported ($0.96) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($0.16), Bloomberg
-$0.79 EPS Expected for Myovant Sciences Ltd (NYSE:MYOV) This Quarter
06:54pm, Tuesday, 11'th Feb 2020
Wall Street analysts expect Myovant Sciences Ltd (NYSE:MYOV) to announce ($0.79) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Myovant S
Myovant's Uterine Fibroid Drug Relugolix Produces Positive Data in a Long-Term Study
09:32pm, Monday, 10'th Feb 2020
The results were consistent with a pair of shorter studies of the combination treatment.
Analysts Offer Insights on Healthcare Companies: Myovant Sciences (MYOV) and Aquestive Therapeutics (AQST)
06:27pm, Monday, 10'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Myovant Sciences (MYOV) and Aquestive Therapeutics (AQST)
Analysts Offer Insights on Healthcare Companies: Myovant Sciences (NYSE: MYOV) and Aquestive Therapeutics (NASDAQ: AQST)
06:27pm, Monday, 10'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Myovant Sciences (
MYOV
–
Research Report
) and Aquestive Therapeutics (
AQST
–
Research Report
) w
TSLA, INO among premarket gainers
02:16pm, Monday, 10'th Feb 2020
vTv Therapeutics (NASDAQ:VTVT) +80% on positive TTP399 data.Taubman Centers (NYSE:TCO) +52% on being acquired by Simon Property Group.Edgewell Personal Care (NYSE:EPC) +21% after Q4 results.Mereo B
Myovant up 11% premarket on long-term relugolix data
02:01pm, Monday, 10'th Feb 2020
Myovant Sciences (NYSE:MYOV) perks up 11% premarket on modest volume in reaction to positive results from a Phase 3 open-label extension study, LIBERTY, evaluating once-daily oral relugolix, combine
Myovant Sciences expects to report results from SPIRIT 2 in 1Q20 MYOV
01:35pm, Monday, 10'th Feb 2020
Myovant Sciences expects to report results from SPIRIT 2 in 1Q20 MYOV
Myovant Sciences expects to submit NDA for relugolix tablet in 2Q20 MYOV
01:34pm, Monday, 10'th Feb 2020
Myovant Sciences expects to submit NDA for relugolix tablet in 2Q20 MYOV
